Dr Jean Lu Presents Renal HCL findings at IDF 2026
Congratulations to Dr Jean Lu on presenting the results of her Renal HCL study at the combined IDF, ADC and Metabolic Diseases Congress in Melbourne. The study explored whether an automated insulin delivery system could help people with diabetes and advanced kidney disease manage their blood sugar better than usual insulin injections. Among 40 participants, those using the automated system spent 73% of their time in the target blood sugar range, compared with 60% on usual care. The observed improvement was found to be a result of fewer periods of high blood sugar, while lower blood sugar levels were uncommon. These encouraging results suggest that automated insulin delivery could be a safe and effective option for improving blood sugar control in people with diabetes and advanced kidney disease.
Dr Jean Lu Presents Renal HCL findings at IDF 2026
Congratulations to Dr Jean Lu on presenting the results of her Renal HCL study at the combined IDF, ADC and Metabolic Diseases Congress in Melbourne. The study explored whether an automated insulin delivery system could help people with diabetes and advanced kidney disease manage their blood sugar better than usual insulin injections. Among 40 participants, those using the automated system spent 73% of their time in the target blood sugar range, compared with 60% on usual care. The observed improvement was found to be a result of fewer periods of high blood sugar, while lower blood sugar levels were uncommon. These encouraging results suggest that automated insulin delivery could be a safe and effective option for improving blood sugar control in people with diabetes and advanced kidney disease.

